Chronic kidney disease is common: What do we do next?

Authors:
  • LSL. A. Stevens
    L. A. Stevens
  • ALA. S. Levey
    A. S. Levey

Abstract
Background. Nephropathy is an indicator of end-organ damage and is a strong predictor of an increased risk of cardiovascular disease and death in patients with diabetes. Screening can lead to early identification and treatment, both of which incur costs. However, identification and treatment may slow or prevent progression to a more expensive stage of the disease and thus may save money. We assessed the health economic impact of screening for nephropathy (microalbuminuria and overt nephropathy) followed by optimal renoprotective-based antihypertensive therapy in a US setting.